TNFSF4 and neoplasm: Selecting patients based on high OX40 and low OX40 ligand expression in T cells in the tumor microenvironment may warrant exploration when targeting OX40 and OX40L, as different tumors have variable levels of expression of OX40-related machinery in T cells.